IMNM Immunome, Inc.: Forvard P/S multiplikatori
Antitela patent portfeli orqali intellektual mulkni himoya qilish raqobatchilar uchun kirishning sezilarli to'sig'ini yaratadi. Kutilayotgan P/S ko'rsatkichi ushbu barqarorlikni aks ettiradi, bunda 741.00 ushbu parametrning miqdorini belgilaydi. Immunome, Inc. (IMNM) maqsadli saraton terapiyasi uchun noyob antitelalarni kashf etishga tayanadi, garchi kompaniya hozirda tijorat sotuvlari boshlanishidan oldin qimmatbaho klinik sinovlarga kapital yo'naltirayotgan bo'lsa-da.
Immunome Bio (IMNM) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunome, Inc.|IMNM - Kompaniyaning jamlangan qarzi|Qarzning balans kapitallashuviga nisbati Immunome Bio|IMNM - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Immunome|Tezkor likvidlik koeffitsiyenti immunome.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMNM - Kompaniyaning sof daromadi|Kelajakdagi foyda Immunome, Inc.|IMNM - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Immunome Corp|IMNM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Immunome Bio|IMNM - Eskirishdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Immunome|IMNM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi immunome.com|IMNM - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Immunome, Inc.
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:IMNM (Immunome)
Immunome, Inc. (IMNM) uchun Clay Sigallning yuqori obro-yuvori va daromadlar baholashining kombinatsiyasi uning investitsiyaviy jozibadorligini belgilaydi. Joriy forward P/S koeffitsiyenti kompaniyaning bozor qiymatini prognoz qilingan savdo hajmi bilan bog'laydi va aktiv haddan tashqari sotib olinganini ko'rsatadi. Ushbu ko'rsatkich spekulyativ sakrashlarni o'z vaqtida aniqlash imkonini berib, ularni real o'sishdan ajratadi. Strukturaviy boshqaruv moslashuvi davrida ushbu metrika bozor optimizmining asosliligini tekshirish uchun filtr vazifasini o'taydi.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori immunovant.com|Narxning prognoz qilingan daromadga nisbati Kiniksa|Forvard narx/daromad multiplikatori Grifols SA (GRFS)|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|VERA - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Dianthus Therapeutics Inc|Pharvaris Corp (PHVS) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori AbCellera Corp|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati precigen.com PGEN|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Zenas Corp (ZBIO)|GOSS - Narxning prognoz qilingan daromadga nisbati|KALV (kalvista.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|SEPN: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pieris Pharma|Forvard narx/daromad multiplikatori SVRA|Rigel Corp (RIGL) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori ANAB|Kapitalizatsiyaning kutilayotgan sotuvga nisbati astriatx.com|Narxning prognoz qilingan daromadga nisbati enGene ENGN|RAPT - Forvard narx/daromad multiplikatori|JBIO - Narxning prognoz qilingan daromadga nisbati|ACRS (Aclaris Therapeutics, Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Kyverna Therapeutics (KYTX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori tizianalifesciences.com|Narxning prognoz qilingan daromadga nisbati Cabaletta Bio|Ventyx Biosciences Inc. - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori THTX|AVTX (Avalo Therapeutics Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori ELDN (Eledon Pharmaceuticals)|Forvard P/S multiplikatori agenusbio.com AGEN|CLYM - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx ZURA (Zura Bio Ltd)|aTyr (ATYR) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Adagene Inc.|IMA (ImageneBio) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Shattuck Therapeutics|Forvard narx/daromad multiplikatori EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori IMUX (Immunic)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Atara Biotherapeutics, Inc. (ATRA)|IFRX - Narxning prognoz qilingan daromadga nisbati|x4pharma.com (XFOR) - Forvard narx/daromad multiplikatori|adicetbio.com (ACET) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Celularity|Forvard narx/daromad multiplikatori INMB|Forvard P/S multiplikatori Barinthus Biotherapeutics Corp|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Q32 Bio Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ibioinc.com|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|Forvard narx/daromad multiplikatori XTL Biopharmaceuticals Ltd (XTLB)|Forvard narx/daromad multiplikatori BOLT (Bolt Biotherapeutics)|Forvard P/S multiplikatori hcwbiologics.com (HCWB)|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ADTX - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati GRI Bio Inc|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Vyome Therapeutics|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati indaptusrx.com INDP|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Allakos Inc (ALLK)|HOOK - Narxning prognoz qilingan daromadga nisbati|IGMS (IGM Biosciences, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ITOS: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Ocean Biomedical Inc|Forvard narx/daromad multiplikatori TCBP|Third Harmonic Bio Inc (THRD) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
